We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
In the UK, low-dose aspirin is licensed for prevention of thrombotic cerebrovascular or cardiovascular disease only in those who already have vascular disease—ie, secondary prevention.
There is no known interaction between oseltamivir and aspirin but aspirin must not be given to anyone younger than 16 year.
Advice for people who have been in possible contact with Junin virus, a virus that causes a disease called Argentine haemorrhagic fever.
Projects granted during 2015 that have a primary purpose of basic research: cardiovascular, blood and lymphatic system.
Advice for people who have come into contact with Lassa virus.
Advice for people who may have come into contact with Chapare virus.
Advice for people who have come into contact with Nipah virus (NiV).
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).